JAZZ
NASDAQ
$243.47
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $261.75 (+7.51%)
Market Cap
$15B
PEG Ratio
0.96
Profit Margin
27.4%
Free Cash Flow Yield
8.57%
Price Chart
Valuation
Market Cap$15B
Forward P/E13.51
PEG0.96
P/S3.37
P/B3.29
Profitability
Total Revenue (TTM)$4.44B
Gross Profit (TTM)$4.06B
EBITDA$2.56M
Profit Margin27.4%
Operating Margin31.5%
EPS-$4.38
Financial Health
Debt-to-Equity118.1%
Free Cash Flow Yield8.57%
Growth & Risk
Revenue 5Y CAGR+12.75%
FCF 5Y CAGR+7.14%
Beta (5Y)0.72
Sharpe Ratio2.10